Investigation Report on China Methylcobalamin Market, 2010-2019

Code: 1602321 | Published: Feb-2016 | Pages: 20 | China Research and Intelligence
Price :
$2,000.00
USD

* Required Fields

$2,000.00

Details

Description
Peripheral neuropathy is a syndrome, which is a single or any combination form of sensory loss, muscle weakness and atrophy, decreased tendon reflex and vasomotion symptoms. The factors which lead to peripheral neuropathy are that the damage of single neural limitation is a common cause of trauma, while multiple single neuropathy occurs secondary to collagen vascular disease; Multiple neuropathy may be caused by toxins, toxic substances, nutrition deficiency, metabolic disease and malignant tumors.
Methylcobalamin, derivative of Vitamin B12, is active Vitamin B12 and the therapeutic drug of peripheral neuropathy. It can promote intraneural nucleic acid, protein and metabolism, facilitate the synthesis of DNA,RNA as well as the synthesis of lecithin lipid, which is the main component of myelin sheath, and accelerate to restore the damaged nerve tissue to improve the transformation of nerve tissue and the disturbance of metabolism. In addition, it also works on restraining unusual exciting conduction of nerve tissue.

Methylcobalamin,. whose trade name is mecobalamin, was developed by Eisai Co., Ltd. and put in the market in Japan in the middle of 1980s.In 1996, mecobalamin entered the Chinese market.
Methylcobalamin developed rapidly after entering China. Its annual sales value increased from less than 200 million CNY in 2005 to 441 million CNY in 2014, with CAGR of 12.32%. It had broad market demand in China. Eisai (Suzhou) Pharmaceutical Co., Ltd, Eisai Co., Ltd. (Japan), Jiangsu Sihuan Bioengineering Co., Ltd, Nanjing Hailing Pharmaceutical Co., Ltd. and NCPC occupy large market share, among which Eisai (Suzhou) Pharmaceutical Co., Ltd occupies most, whose annual market share of sales value was over 40% in 2014.
It is predicted that in next few years, the incidence of peripheral neuropathy in China will gradually rise, making the market scale of methylcobalamin continue to increase.

Through this report, readers can get the followings and more information:
-Market scale of Methylcobalamin in China
-Market Competitive pattern of Methylcobalamin in China
-Sales price of Methylcobalamin made by different enterprises in China
-Market outlook of Methylcobalamin in China

The author recommends the following people to purchase this report:
- Production enterprises of methylcobalamin drugs
-Investors/research institutions focusing on Chinese pharmaceutical market
--If interested in Chinese pharmaceutical market, you can contact CRI for customized survey service.

Table of Contents

Table of Contents
1 Related Concepts of Methylcobalamin
1.1 Indications
1.2 Sales Status in Global Market

2 Market Profile of Methylcobalamin in China
2.1 Patent and Approval Information of Methylcobalamin in China
2.2 Major Manufacturing Enterprises
2.3 Market Scale

3 Survey on Methylcobalamin Sales in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions

4 Survey on Market Share of Major Methylcobalamin Production Enterprises in China, 2010-2014
4.1 Market Share of Producing Businesses by Sales Value
4.2 Market Share of Producing Businesses by Sales Volume

5 Survey on Dosage Forms of Methylcobalamin in China, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume

6 Reference Sales Price of Methylcobalamin in Chinese Hospitals in 2014
6.1 North China Pharmaceutical Group Corp. (NCPC)
6.2 Eisai (Suzhou) Pharmaceutical Co., Ltd.
6.3 Eisai Co., Ltd. (Japan)
6.4 Nanjing Hailing Pharmaceutical Co., Ltd.
6.5 Jiangsu Sihuan Bioengineering Co., Ltd.

7 Major Production Enterprises of Methylcobalamin in Chinese Market, 2010-2014
7.1 North China Pharmaceutical Group Corp. (NCPC)
7.2 Eisai (Suzhou) Pharmaceutical Co., Ltd.
7.3 Eisai Co., Ltd. (Japan)
7.4 Nanjing Hailing Pharmaceutical Co., Ltd.
7.5 Jiangsu Sihuan Bioengineering Co., Ltd.

8 Market Outlook of Methylcobalamin in China, 2015-2019
8.1 Prediction of Market Size
8.2 Prediction of Competitive Pattern
Selected Charts
Chart Patent Status of Methylcobalamin in China
Chart Approval Information of Methylcobalamin in China
Chart Sales Status of Methylcobalamin in China
Chart Sales Value of Methylcobalamin in China, 2010-2014
Chart Sales Value of Methylcobalamin in Some Regions of China, 2010-2014
Chart Sales Volume of Methylcobalamin in China, 2010-2014
Chart Sales Volume of Methylcobalamin in Some Regions of China, 2010-2014
Market Share of Corporations of TOP5 Methylcobalamin Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Suzhou) in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Eisai (Japan) in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Jiangsu Sihuan in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by Nanjing Hailing in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Produced by NCPC in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Injection in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Tablet in China, 2010-2014
Chart Sales Value and Market Share of Methylcobalamin Capsule in China, 2010-2014
Chart Sales Price of Methylcobalamin Produced by NCPC in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Eisai (Suzhou) in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Eisai (Japan) in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Nanjing Hailing Pharmaceutical Co., Ltd. in Some Chinese Cities in 2014
Chart Sales Price of Methylcobalamin Produced by Jiangsu Sihuan Bioengineering Co., Ltd. in Some Chinese Cities in 2014

Companies Mentioned

North China Pharmaceutical Group Corp. (NCPC), Eisai (Suzhou) Pharmaceutical Co., Ltd. , Eisai Co., Ltd. (Janpan), Nanjing Hailing Pharmaceutical Co., Ltd., Jiangsu Sihuan Bioengineering Co., Ltd.

Report Format

Following are different modes of Licenses.

a. Single User License:
This license allows only one person to use the report. This person can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people. Unless you purchase a Site License or a Global Site License, a Single User License must be purchased for every single person that wishes to use the report within the same enterprise.

b. Single Site License:
This license allows unlimited users to use the report within one company location, e.g. a regional office. These users can use the report on any computer and may take print outs of the report but must take care of not sharing the report (or any information contained therein) with any other individual or people.

c. Global Site License:
A Global Site License (or Enterprise wide Site License or Global License) is a license granted to original purchaser, who can share a report with other employees and authorized Users of the same organization.

Quick Help

1. How do you deliver the reports?
The delivery of reports is depends on format & mode of license of report(s). Following are different kinds of formats of report(s) and their delivery options :

a. Electronic Format – Through email from Publisher
Report will be sent to your username email address in PDF, Excel, PowerPoint or any other electronic / softcopy format by publisher.
Delivery Time: 12 to 48 hours [depending on time difference or occurrences of national holidays]

b. Hard Copy or Printed Format or CD-Rom – Through Mail or Courier from Publisher
Report will be sent through mail / courier delivery to your shipping address by publisher.
Delivery Time: Less than, few weeks [depending on time difference or occurrences of national holidays]


2. How can I make payment for publications I purchase?
You could be able to make the payment, in following ways:

a. Online Secure Payment through Credit Card Payment : We accept Visa, Master, AMEX Cards & CCAvenue
b. Transfer of fund to our bank account via Bank transfer or Wire transfer
c. Payment via DD or Cheque
d. Paypal


3. Is it safe to use my credit card on MarketinfoResearch?
Your personal information and online tranaction on Marketinfo Research is secure, private, and tamper-proof. All credit card payments are processed through secure and trusted payment gateways.

If you have a more question about our publications please see our FAQs section or contact us now at cs@marketinforesearch.com.


Our Clients